一家去年亏了13.6亿、今年前三季度还在亏钱的A股公司，突然被三大国际投行抢购——高盛、摩根大通、巴克莱集体挤进前十大股东，短短三个月股价暴 涨313%。 外资难道在"赌"亏损股？ | 2025-09-30 2025-06-30 | 2025-03-31 | 2024-12-31 | | 2024-00-20 核胶禁或热门的概念题材 | | | --- | --- | --- | --- | --- | --- | | 前十大流通股东累计持有:1.70亿股,累计占流通股比:34.02%,较上期减少934.75万股 | | | | | | | 机构或基金名称 | | 持有数量(股) | 持股变化(股) | 占流通股比例 | 变动比例 | | 汕头市天际有限公司 | | 6558.81万 | +-1020.11 | 13.09% | + -13.46 | | | | | 万 | | 0/0 | | 常熟市新华化工有限公司 | | 3513.60万 | +-750.00万 | 7.01% | $ -17.59 | | | | | | | 0/0 | | 江苏瑞泰新能源材料股份有限公司 | | 3004.29万 | ...

Core Viewpoint - BASF has signed a long-term contract with Air Liquide's subsidiary SCIPIG and Shanghai Shenji Energy Environmental Technology Co., Ltd. to produce low-carbon footprint MDI using biogas, marking a significant step in sustainable chemical production in Shanghai [2]. Group 1: Collaboration and Production - The collaboration aims to utilize biogas for the production of bio-based hydrogen and carbon monoxide, which will be used by BASF to produce MDI and its derivatives with reduced carbon footprint characteristics [2]. - This partnership is the first of its kind in Shanghai, utilizing biogas for local production of bio-hydrogen and carbon monoxide, fully compliant with ISCC Plus standards [2]. Group 2: Industry Leadership in Bio-based MDI - BASF is a leader in the production of bio-based MDI, having successfully produced the world's first biomass-balanced MDI in October 2023 and forming strategic partnerships for further development [3]. - Covestro has also made significant strides in the bio-based MDI market, securing its first ISCC PLUS certified commercial order for low-carbon footprint MDI in November 2023 [3]. Group 3: Market Dynamics and Competition - The MDI market is characterized by high technical barriers and limited global producers, with major players including Wanhua Chemical, BASF, and Covestro, among others [6]. - The MDI prices are subject to fluctuations due to maintenance and external factors, with significant maintenance scheduled for major producers in late 2025 [7]. - The industry is undergoing a transformation with increased domestic capacity in China, positioning the country as a net exporter of MDI [6].

证券日报网讯和邦生物11月14日在互动平台回答投资者提问时表示，根据公司目前的规划，公司将抓住 磷矿石销售的景气时机，尽快推动磷矿石的开采，公司已启动了Wonarah磷矿一期70万吨/年产能的建设 规划，此后将根据市场行情及资金安排确定后续项目规划。 （文章来源：证券日报） ...

Core Viewpoint - Jiangsu Sop Chemical Co., Ltd. plans to raise up to 1.5 billion yuan for the "Vinyl Acetate and EVA Integration Project (Phase I)" with a post-tax internal rate of return of 12.64% and a payback period of 8.57 years [1] Investment Project Overview and Return Analysis - The total investment for the project is 3.226 billion yuan, with construction investment at 2.636 billion yuan and additional costs totaling 480 million yuan [2] - The project aims to achieve an annual production capacity of 330,000 tons of vinyl acetate, generating an expected annual revenue of 3.142 billion yuan, with vinyl acetate product revenue accounting for 83.66% [2] - The internal rate of return of 12.64% is higher than Rongsheng Petrochemical's similar project (11.77%) but lower than Lianhong Xinke's (16.03%), indicating a reasonable industry level [2] - The unit investment per ton for this project is 97.7552 million yuan, lower than Shuangxin Environmental Protection (134.1157 million yuan) but slightly higher than Lianhong Xinke (65.0458 million yuan) [2] Project Necessity and Capacity Consumption - The project benefits from synergies with existing products, and construction is expected to be completed by 2026, with production starting in 2027 [3] - The estimated selling price of the product is set conservatively at 9,000 yuan/ton, which is 4.87% lower than the historical average [3] - The projected sales rate is expected to reach 100% due to increasing demand in downstream industries like photovoltaic EVA [3] Financial Condition and Operating Data Analysis - The company's gross profit margin has fluctuated from 15.58% in 2022 to 8.40% in the first half of 2025, primarily due to a decrease in sales price [4] - The net profit for 2024 is projected to be 213 million yuan, a significant increase of 1,088.11% driven by a 36.82% increase in vinyl acetate sales [4] Asset Quality Indicators - As of June 2025, accounts receivable and financing balances reached 689 million yuan, a 54.92% increase from the end of 2024 [5] - Inventory balance is 454 million yuan, with a lower-than-average impairment provision of 0.84% due to high inventory turnover [5] Monetary Funds and Financing Needs - The company currently has 906 million yuan in cash, with 831 million yuan available for use [6] - A funding gap of 1.865 billion yuan is anticipated from Q3 2025 to 2026, and the 1.5 billion yuan raised will help alleviate financial pressure [6] Accountant's Review Opinion - The accountant believes the investment structure of the project is reasonable and consistent with comparable industry projects, with key metrics reflecting industry cyclicality [7] - The company has adequately accounted for receivables and inventory impairment provisions, and there are no signs of asset impairment [8]

点击查看公告原文>> 声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 责任编辑：小浪快报 江苏索普化工股份有限公司（证券代码：600746，证券简称：江苏索普）11月15日发布公告称，公司已 完成并披露对上海证券交易所（以下简称"上交所"）关于向特定对象发行A股股票申请文件审核问询函 的回复。本次发行事项仍需经上交所审核通过及中国证监会同意注册，最终能否实施及实施时间存在不 确定性。 公告显示，江苏索普于2025年10月30日收到上交所出具的《关于江苏索普化工股份有限公司向特定对象 发行股票申请文件的审核问询函》（上证上审(再融资)〔2025〕331号）。随后，公司会同相关中介机 构对问询函所列问题进行了认真研究和逐项落实，按要求完成了说明和论证 ...

格隆汇11月14日｜丰元股份(002805.SZ)发布投资者关系活动记录表，截至目前，公司已建成的磷酸铁 锂产能共计22.5万吨，总体产能规划达30万吨，剩余7.5万吨产能处于在建阶段。2025年第四季度以来， 受益于下游需求的持续增长，公司产品的有效产能利用率保持在较高水平。公司针对客户对产品差异化 需求研发的高压实密度产品目前已经进入量产阶段。 ...

华谊集团公告称，2024年3月29日，其全资子公司新材料公司和控股子公司广西新材料被阿克马公司起 诉，对方称二者侵犯其专利权，申请经济赔偿4.3亿元及承担全部诉讼费。2025年11月14日，原告变更 诉讼请求，现请求新材料公司赔偿4.3亿元，广西新材料对其中1.1亿元承担连带赔偿责任。案件一审未 判决，对公司利润影响以法院生效判决为准。 ...

格隆汇11月14日｜合盛硅业大宗交易成交411.3万股，成交额2.26亿元，占当日总成交额的10.17%，成 交价55.06元，较市场收盘价59.61元折价7.63%。 ...

Core Viewpoint - The average stock price of A-shares is 13.92 yuan, with 20 stocks priced below 2 yuan, the lowest being *ST Yuan Cheng at 0.58 yuan [1] Stock Price Distribution - As of November 14, the Shanghai Composite Index closed at 3990.49 points, with a relatively small proportion of high-priced and low-priced stocks in the A-share market [1] - Among the low-priced stocks, 8 are ST stocks, accounting for 40% of those priced below 2 yuan [1] Market Performance - Out of the low-priced stocks, 18 saw an increase today, with notable gains from Rongsheng Development (10.17%), Yongtai Energy (9.82%), and *ST Jinke (4.76%) [1] Low-Priced Stock Rankings - The table lists various low-priced stocks, including their latest closing prices, daily price changes, turnover rates, price-to-book ratios, and industries [1] - For example, *ST Yuan Cheng has a closing price of 0.58 yuan, while *ST Suwu and *ST Jinke are at 0.97 yuan and 1.54 yuan respectively [1]

Investment Rating - The report assigns a "Buy" rating for the company, with a target price of HKD 1.21 based on a projected PE of 11 times for 2026 [44]. Core Insights - Tsaker New Energy Tech is a globally recognized manufacturer of dye/pigment intermediates and battery materials, with a focus on iron phosphate as a new opportunity [1][28]. - The company has shown a compound annual growth rate (CAGR) of 10% in revenue from 2015 to 2024, with a shift in revenue structure towards pigment intermediates and battery materials [7][12]. - The company is the leading domestic producer of iron phosphate, with a production capacity of 100,000 tons per year [35]. Summary by Sections Company Overview - Tsaker New Energy Tech has a history dating back to 1986, employing around 2,000 staff, with headquarters in Beijing and production bases in Hebei and Shandong [3][4]. - The company operates in three main segments: dye and agricultural chemical intermediates, pigment intermediates and new materials, and battery materials [4][28]. Financial Performance - The company experienced a significant decline in net profit in 2023, with a year-on-year decrease of 88%, but returned to profitability in the first half of 2025 [12][44]. - Revenue from the pigment intermediates and new materials segment increased by approximately 28.2% to around CNY 283 million in the first half of 2025 [21]. Product Development - The company is expanding its product offerings, with new products like BPDA entering mass production, contributing positively to overall profitability [21][35]. - The pigment intermediates segment includes products such as DMSS, DATA, and DMAS, which are used in high-performance organic pigments and food colorants [18][20]. Market Position - The company has established long-term partnerships with well-known enterprises in the pigment and food additive industries, enhancing its market position [25][26]. - The organic pigment market in China has seen an increase in concentration, with the CR3 rising from 30% to 35% and CR5 from 38% to 48% [21]. Future Outlook - The company is expected to see a recovery in net profit, with projections of CNY 0.28 million, CNY 0.93 million, and CNY 1.30 million for 2025 to 2027 [44]. - The report highlights the potential for growth in the battery materials segment, particularly in iron phosphate, as the demand for lithium batteries continues to rise [35][38].